Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

BACKGROUND: In cancer screening trials where the primary outcome is target cancer-specific mortality, the unbiased determination of underlying cause of death (UCD) is crucial. To minimise bias, the UCD should be independently verified by expert reviewers, blinded to death certificate data and trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Naomi J, Hill, Elizabeth M, Ng, Siaw Yein, Martin, Richard M, Metcalfe, Chris, Donovan, Jenny L, Evans, Simon, Hughes, Laura J, Davies, Charlotte F, Hamdy, Freddie C, Neal, David E, Turner, Emma L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429825/
https://www.ncbi.nlm.nih.gov/pubmed/25613468
http://dx.doi.org/10.1186/1471-2288-15-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429825/
https://www.ncbi.nlm.nih.gov/pubmed/25613468
http://dx.doi.org/10.1186/1471-2288-15-6

Ejemplares similares